GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR) announced results from the largest study to date evaluating stroke detection with its Swoop portable MRI system, showing the device can identify strokes ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI ...
GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR) has enrolled the first patient in its Contrast PMR study, a multi-center clinical trial evaluating the use of contrast agents with its portable MRI ...
The largest dataset to date on stroke detection with the Swoop® system demonstrates the ability to identify small strokes rapidly and reliably, reinforcing its clinical value for acute care and ...
The MarketWatch News Department was not involved in the creation of this content. Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative ...
Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million ...
SAN JUAN - Hyperfine, Inc. (NASDAQ:HYPR) announced that its portable Swoop MRI system demonstrated 92% concordance with standard high-field MRI in identifying intracranial pathology, according to ...